Marie Eikemo1,2,3, Guro E Løseth4, Tom Johnstone5, Johannes Gjerstad6,7, Frode Willoch7, Siri Leknes4,8. 1. Norwegian Center for Addiction Research (SERAF), University of Oslo, PO BOX 1039 Blindern, 0315, Oslo, Norway. m.h.eikemo@medisin.uio.no. 2. Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. m.h.eikemo@medisin.uio.no. 3. Department of Psychology, University of Oslo, Oslo, Norway. m.h.eikemo@medisin.uio.no. 4. Department of Psychology, University of Oslo, Oslo, Norway. 5. School of Psychology and CLS, University of Reading, Reading, UK. 6. Norwegian Institute of Occupational Health (STAMI), Oslo, Norway. 7. Department of Basic Medical Sciences, University of Oslo, Oslo, Norway. 8. The Intervention Center, Oslo University Hospital, Oslo, Norway.
Abstract
BACKGROUND: Rodent models highlight the key role of μ-opioid receptor (MOR) signaling in palatable food consumption. In humans, however, the effects of MOR stimulation on eating and food liking remain unclear. OBJECTIVES: Here, we tested sweet pleasantness experience in humans following MOR drug manipulations. We hypothesized that behaviors regulated by the endogenous MOR system would be enhanced by MOR agonism and decreased by antagonism. In line with rodent findings, we expected the strongest drug effects for the sweetest (high-calorie) sucrose stimuli. As very sweet stimuli are considered aversive by many people (called sweet dislikers), we also assessed whether MOR manipulations affect pleasantness ratings of sucrose-water stimuli differently depending on subjective and objective value. METHODS: In a bidirectional psychopharmacological cross-over study, 49 healthy men underwent a sweet taste paradigm following double-blind administration of the MOR agonist morphine, placebo, and the opioid antagonist naltrexone. RESULTS: As hypothesized, MOR stimulation with morphine increased pleasantness of the sweetest of five sucrose solutions, without enhancing pleasantness of the lower-sucrose solutions. For opioid antagonism, an opposite pattern was observed for the sweetest drink only. The observed drug effects on pleasantness of the sweetest drink did not differ between sweet likers and dislikers. CONCLUSIONS: The bidirectional effect of agonist and antagonist treatment aligns with rodent findings showing that MOR manipulations most strongly affect the highest-calorie foods. We speculate that the MOR system promotes survival in part by increasing concordance between the objective (caloric) and subjective (hedonic) value of food stimuli, so that feeding behavior becomes more focused on the richest food available.
RCT Entities:
BACKGROUND: Rodent models highlight the key role of μ-opioid receptor (MOR) signaling in palatable food consumption. In humans, however, the effects of MOR stimulation on eating and food liking remain unclear. OBJECTIVES: Here, we tested sweet pleasantness experience in humans following MOR drug manipulations. We hypothesized that behaviors regulated by the endogenous MOR system would be enhanced by MOR agonism and decreased by antagonism. In line with rodent findings, we expected the strongest drug effects for the sweetest (high-calorie) sucrose stimuli. As very sweet stimuli are considered aversive by many people (called sweet dislikers), we also assessed whether MOR manipulations affect pleasantness ratings of sucrose-water stimuli differently depending on subjective and objective value. METHODS: In a bidirectional psychopharmacological cross-over study, 49 healthy men underwent a sweet taste paradigm following double-blind administration of the MOR agonist morphine, placebo, and the opioid antagonist naltrexone. RESULTS: As hypothesized, MOR stimulation with morphine increased pleasantness of the sweetest of five sucrose solutions, without enhancing pleasantness of the lower-sucrose solutions. For opioid antagonism, an opposite pattern was observed for the sweetest drink only. The observed drug effects on pleasantness of the sweetest drink did not differ between sweet likers and dislikers. CONCLUSIONS: The bidirectional effect of agonist and antagonist treatment aligns with rodent findings showing that MOR manipulations most strongly affect the highest-calorie foods. We speculate that the MOR system promotes survival in part by increasing concordance between the objective (caloric) and subjective (hedonic) value of food stimuli, so that feeding behavior becomes more focused on the richest food available.
Entities:
Keywords:
Food; Human; Morphine; Naltrexone; Opioid system
Authors: Michal Wronski; Dominika Skrok-Wolska; Jerzy Samochowiec; Marcin Ziolkowski; Lukasz Swiecicki; Przemyslaw Bienkowski; Agnieszka Korkosz; Paweł Zatorski; Wojciech Kukwa; Anna Scinska Journal: Alcohol Alcohol Date: 2007-01-31 Impact factor: 2.826
Authors: Marta Peciña; Tiffany Love; Christian S Stohler; David Goldman; Jon-Kar Zubieta Journal: Neuropsychopharmacology Date: 2014-10-13 Impact factor: 7.853
Authors: R L McLeod; L E Parra; J C Mutter; C H Erickson; G J Carey; D B Tulshian; A B Fawzi; A Smith-Torhan; R W Egan; F M Cuss; J A Hey Journal: Br J Pharmacol Date: 2001-03 Impact factor: 8.739
Authors: Marie Eikemo; Philipp P Lobmaier; Mads L Pedersen; Nikolaj Kunøe; Anna Maria Matziorinis; Siri Leknes; Monica Sarfi Journal: Neuropsychopharmacology Date: 2019-03-31 Impact factor: 7.853
Authors: Chantal Berna; Siri Leknes; Asma H Ahmad; Roisin N Mhuircheartaigh; Guy M Goodwin; Irene Tracey Journal: J Neurosci Date: 2018-09-10 Impact factor: 6.167
Authors: Juliana L Giacomini; Emma Geiduschek; Ryan A Selleck; Ken Sadeghian; Brian A Baldo Journal: Neuropsychopharmacology Date: 2021-07-05 Impact factor: 8.294
Authors: Samantha O Brown; Devin P Effinger; Rodrigo A Montoro; Nabil Daddaoua; Zuzana Justinova; Megan J Moerke; Charles W Schindler; Hank P Jedema; Charles W Bradberry Journal: Neuropsychopharmacology Date: 2021-04-08 Impact factor: 8.294